Biotech Values

[DewDiligence]

>Refusal to disclose or improper disclosure will result in publications and presentations being cancelled.<

And what if the presentation has already been presented or the paper has already been published?

If ASCO sincerely wanted to foster fairness in the financial arena, they would forego the gag rule that causes all the trouble in the first place.

Instead, ASCO has opted for a propaganda campaign so the public will think they are an agent for ethical behavior when exactly the opposite is true.